Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2015-06-29 Transaction in Own Shar…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (263 characters) and explicitly states that Novozymes has bought back a specific number of shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). The final line, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format), strongly suggests this is a brief notification about a transaction rather than the full regulatory filing detailing the transaction. This aligns best with the 'Transaction in Own Shares' category (POS), which covers share repurchases. It is not an announcement of a report (RPA/RNS) because it contains substantive transactional data, not just a pointer to another document.
2015-06-29 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document details specific transactions where Novozymes has bought back its own B-shares as part of a previously announced share repurchase program (aktietilbagekøbsprogram). It lists the number of shares bought, the average price, and the total transaction value for the period ending June 26, 2015. This activity directly corresponds to the definition of a company reporting transactions in its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). The document is a direct report of the activity, not an announcement of a report, and its content is highly specific to share repurchases.
2015-06-29 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program' initiated on February 2, 2015. This action directly relates to the company acquiring its own shares. The classification code corresponding to the report of the company buying back or selling its own shares is 'POS' (Transaction in Own Shares). The document is very short and mentions reading the full announcement in PDF format, but the core content is the transaction itself, making POS more specific than RPA or RNS.
2015-06-22 English
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (263 characters) and describes a transaction where Novozymes bought back its own shares under a previously announced share repurchase program. The key phrases are 'købt i alt 2.828.681 aktier' (bought a total of 2,828,681 shares) and 'aktietilbagekøbsprogram' (share repurchase program). This directly corresponds to the definition of 'Transaction in Own Shares' (POS). The final sentence, 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format), suggests this might be a brief announcement, but the core content is a transaction report, making POS the most specific fit over RPA or RNS.
2015-06-22 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 100% confidence The document text is very short (263 characters) and explicitly states that Novozymes has bought back a specific number of shares under a previously announced share repurchase program ('aktietilbagekøbsprogram'). The final line, 'Læs hele meddelelsen i pdf format' (Read the entire announcement in pdf format), strongly suggests this is a brief announcement about a transaction rather than the full regulatory filing detailing the transaction. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchases. Given the brevity and the instruction to read the full document elsewhere, it is a notification of the transaction itself.
2015-06-15 Danish
Transaction in Own Shares 2015
Transaction in Own Shares Classification · 99% confidence The document details specific transactions where Novozymes has bought back its own B-shares under a previously announced share repurchase program (aktietilbagekøbsprogram). It provides daily transaction volumes, average purchase prices, and the total number of own shares held after the transactions. This activity directly corresponds to the definition of a company reporting transactions in its own shares. The relevant filing type is 'Transaction in Own Shares' (POS). The document is a specific announcement about share repurchases, not a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core data itself.
2015-06-15 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.